Skeletal Effects of Inducible ER alpha Deletion in Osteocytes in Adult Mice

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11150%2F22%3A10449462" target="_blank" >RIV/00216208:11150/22:10449462 - isvavai.cz</a>

Alternative codes found

RIV/00179906:_____/22:10449462

Result on the web

<a href="https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=7kH0-Y6oZb" target="_blank" >https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=7kH0-Y6oZb</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1002/jbmr.4644" target="_blank" >10.1002/jbmr.4644</a>

Result language

angličtina

Original language name

Skeletal Effects of Inducible ER alpha Deletion in Osteocytes in Adult Mice

Original language description

Estrogen is known to regulate bone metabolism in both women and men, but substantial gaps remain in our knowledge of estrogen and estrogen receptor alpha (ER alpha) regulation of adult bone metabolism. Studies using global ER alpha-knockout mice were confounded by high circulating sex-steroid levels, and osteocyte/osteoblast-specific ER alpha deletion may be confounded by ER alpha effects on growth versus the adult skeleton. Thus, we developed mice expressing the tamoxifen-inducible CreERT2 in osteocytes using the 8-kilobase (kb) Dmp1 promoter (Dmp1(CreERT2)). These mice were crossed with ER alpha(fl//fl) mice to create ER alpha Delta Ocy mice, permitting inducible osteocyte-specific ER alpha deletion in adulthood. After intermittent tamoxifen treatment of adult 4-month-old mice for 1 month, female, but not male, ER alpha Delta Ocy mice exhibited reduced spine bone volume fraction (BV/TV (-20.1%, p = 0.004) accompanied by decreased trabecular bone formation rate (-18.9%, p = 0.0496) and serum P1NP levels (-38.9%, p = 0.014). Periosteal (+65.6%, p = 0.004) and endocortical (+64.1%, p = 0.003) expansion were higher in ER alpha Delta Ocy mice compared to control (Dmp1(CreERT2)) mice at the tibial diaphysis, reflecting the known effects of estrogen to inhibit periosteal apposition and promote endocortical formation. Increases in Sost (2.1-fold, p = 0.001) messenger RNA (mRNA) levels were observed in trabecular bone at the spine in ER alpha Delta Ocy mice, consistent with previous reports that estrogen deficiency is associated with increased circulating sclerostin as well as bone SOST mRNA levels in humans. Further, the biological consequences of increased Sost expression were reflected in significant overall downregulation in panels of osteoblast and Wnt target genes in osteocyte-enriched bones from ER alpha Delta Ocy mice. These findings thus establish that osteocytic ER alpha is critical for estrogen action in female, but not male, adult bone metabolism. Moreover, the reduction in bone formation accompanied by increased Sost, decreased osteoblast, and decreased Wnt target gene expression in ER alpha Delta Ocy mice provides a direct link in vivo between ER alpha and Wnt signaling. (c) 2022 American Society for Bone and Mineral Research (ASBMR).

Czech name

—

Czech description

—

Type

J_imp - Article in a specialist periodical, which is included in the Web of Science database

CEP classification

—

OECD FORD branch

30202 - Endocrinology and metabolism (including diabetes, hormones)

Project

—

Continuities

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year

2022

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Name of the periodical

Journal of Bone and Mineral Research

ISSN

0884-0431

e-ISSN

1523-4681

Volume of the periodical

37

Issue of the periodical within the volume

9

Country of publishing house

US - UNITED STATES

Number of pages

11

Pages from-to

1750-1760

UT code for WoS article

000828895500001

EID of the result in the Scopus database

2-s2.0-85134468346